LATEST ONCOPRESCRIBE UPDATES
Omitting Axillary Lymph Node Dissection in Breast Cancer with Sentinel-Node Metastases
FDA Approves ENHERTU® for Unresectable or Metastatic HER2-Positive Solid Tumors
April 2024: Current Tumor-Agnostic Therapies
Enfortumab Vedotin plus Pembrolizumab: A Breakthrough in Locally Advanced or Metastatic Urothelial Carcinoma
Novel Prognostic Factors for Treatment-Free Remission in Chronic Myeloid leukemia
Neoadjuvant KEYTRUDA® plus Chemotherapy Significantly Improves EFS in Early Stage High Risk Triple Negative Breast Cancer
Metformin May Reduce the Risk of Cancers, Especially GI Malignancies
FDA Approves BREYANZI®, First CAR-T Cell Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma